| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | IMPERVA INC | 105,300 | 4,496,000 | 0.37% | ||
| 52 | REPROS THERAPEUTICS INC | 508,375 | 4,367,000 | 0.36% | ||
| 53 | DOW CHEM CO | 76,300 | 3,661,000 | 0.30% | ||
| 54 | APPLIED DNA | 1,175,000 | 3,043,000 | 0.25% | ||
| 55 | ROYCE VALUE TR INC | 198,396 | 2,841,000 | 0.23% | ||
| 56 | ADAMS DIVERSIFIED EQUITY FD | 166,689 | 2,327,000 | 0.19% | ||
| 57 | PARATEK PHARMACEUTICALS INC | 66,635 | 2,083,000 | 0.17% | ||
| 58 | HERTZ GLOBAL HOLDINGS INC COM | 72,500 | 1,572,000 | 0.13% | ||
| 59 | APPLIED DNA SCIENCES INC | 860,000 | 903,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000040417-15-000046, filed 2015.04.30).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
